Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vanguard U.S. Momentum Factor ETF
(NY:
VFMO
)
192.26
-0.05 (-0.03%)
Official Closing Price
Updated: 8:00 PM EST, Nov 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vanguard U.S. Momentum Factor ETF
< Previous
1
2
Next >
Uber COO Says Robotaxi Tech Is Largely Ready But Hardware Costs Are Still Too High
↗
November 12, 2025
Uber has partnerships in place with multiple robotaxi companies, including Pony AI, WeRide and Alphabet Inc’s Waymo.
Via
Stocktwits
Topics
Artificial Intelligence
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance
↗
November 12, 2025
The company now expects pro forma net revenue for the full year in a range of $390 million to $410 million, higher than a Wall Street estimate of $283.66 million.
Via
Stocktwits
Topics
Earnings
2 Vanguard ETFs to Buy Hand Over Fist and 1 to Avoid
↗
November 12, 2025
Low-cost ETFs are excellent ways to build a diversified stock portfolio without incurring high fees.
Via
The Motley Fool
Topics
ETFs
Uber In Talks With Getir To Expand Delivery Services In Turkey: Report
↗
November 06, 2025
Via
Stocktwits
BHVN Stock Tumbled A Whopping 44% Today – What Did The FDA Letter Say?
↗
November 05, 2025
Via
Stocktwits
Carvana Stock In Spotlight After 6% Slide Today: BTIG Maintains ‘Buy’ Rating
↗
October 17, 2025
Via
Stocktwits
Jefferies CEO Claims Bank Was ‘Defrauded’ By Bankrupt Auto Supplier First Brands Group
↗
October 17, 2025
Via
Stocktwits
Topics
Bankruptcy
Supply Chain
Jeff Bezos Reportedly Says People Should Be Thrilled About AI: ‘Don’t See How Anybody Can Be Discouraged Who Is Alive’
↗
October 17, 2025
Via
Stocktwits
Fiserv Shares Plunge 44% In Record One-Day Drop As Company Gets Wall Street Downgrades On Leadership Changes, Forecast Cuts
↗
October 29, 2025
Wolfe Research downgraded Fiserv to ‘Peer Perform’ from ‘Outperform,’ according to TheFly, on the heels of the guidance cut that it says "raised structural concerns."
Via
Stocktwits
BridgeBio Shares Second Positive Late-Stage Study Result In A Week – Calcium Disorder Drug Trial Yields Positive Results
↗
October 29, 2025
76% of the 67 participants administered Encaleret in the trial achieved both serum and urine calcium within the respective target ranges after 24 weeks of treatment.
Via
Stocktwits
Fiserv Stock Plunges 32% As New CFO Paul Todd Steps In Amid Leadership Overhaul, Profit Warning
↗
October 29, 2025
Fiserv now expects 2025 adjusted earnings per share to come between $8.50 and $8.60, down from the previous forecast of $10.15 to $10.30.
Via
Stocktwits
Tango Therapeutics Stock Soars Pre-Market On $225M Financing, Positive Study Data For Cancer Therapy
↗
October 23, 2025
CEO Barbara Weber said that across the 16 cancer types enrolled in the trial, the objective response rate (ORR) was 27% in patients with a median follow-up of 9.4 months.
Via
Stocktwits
Eli Lilly Says Verzenio Reduced Risk of Death In Late-Stage Trial In Some Breast Cancer Patients
↗
October 17, 2025
Via
Stocktwits
Boston Scientific To Acquire Privately-Held Pain Solutions Developer Nalu Medical For About $533M
↗
October 17, 2025
Via
Stocktwits
Sana Biotech Stock Jumps A Whopping 35% After Eric Jackson Calls It ‘Next 100-Bagger Platform’
↗
October 15, 2025
Via
Stocktwits
AnaptysBio Stock Gets A Price Target Hike After Announcing Plan To Separate Royalty, Biopharma Businesses – Check Out The New Level
↗
September 30, 2025
Via
Stocktwits
Arcturus Therapeutics Stock Plunges Over 57% Today: What’s Causing The Sell-Off?
↗
October 22, 2025
The company said that treatment-related adverse events were observed in the study for the first few doses but ceased with continuous dosing.
Via
Stocktwits
FDA Approves Alzheimer’s Test Developed By Roche In Collaboration With Eli Lilly
↗
October 13, 2025
The blood-based test is aimed at aiding the initial assessment for Alzheimer’s disease and other causes of cognitive decline in the primary-care setting in patients aged 55 and older.
Via
Stocktwits
Apollo Global Eyes Spanish Market With Focus On Energy, Data Centers, And Infrastructure: Report
↗
October 08, 2025
According to a Bloomberg News report, these sectors are where Apollo will be looking for players with the “biggest needs.”
Via
Stocktwits
Topics
Government
Eli Lilly Terminates Study Of Bimagrumab In Obesity
↗
September 25, 2025
Via
Stocktwits
Eli Lilly Announces Plan To Construct New $6.5B Facility In Texas
↗
September 23, 2025
Via
Stocktwits
Scholar Rock In Spotlight After FDA Refuses To Approve Muscular Atrophy Treatment Over Third-Party Manufacturing Facility Issues
↗
September 23, 2025
Via
Stocktwits
KalVista Pharmaceuticals’ Hereditary Angioedema Drug Approved In EU, Switzerland: Retail Sees Stock Rallying To $22 In A Year
↗
September 19, 2025
Via
Stocktwits
Uber Inks Partnership With Flytrex For Drone Delivery In US: Retail Sees Stock ‘Going Higher For Longer’
↗
September 18, 2025
Via
Stocktwits
Eli Lilly To Set Up $5B Facility In Virginia – More Details Inside
↗
September 16, 2025
Via
Stocktwits
Roivant Stock Rises After Drug Achieves Goals In Late-Stage Study: Retail Sees Further Rally To $17
↗
September 17, 2025
Once-daily oral Brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared to placebo on the primary endpoint and all key secondary endpoints in the study,...
Via
Stocktwits
Duolingo Stock Dips After Citigroup Lowers Price Target – Here’s What The Analyst Said About Duocon Event
↗
September 17, 2025
Citigroup maintained a ‘Buy’ rating and noted that Duolingo's product announcements this year had a lower profile relative to the past.
Via
Stocktwits
Topics
Artificial Intelligence
Ralph Lauren Unveils Three-Year Outlook – Here Are The Key Points
↗
September 16, 2025
Via
Stocktwits
Dave & Buster’s Sees Wall Street Downgrades, Yet Retail Sentiment Red-Hot
↗
September 16, 2025
UBS said that while Dave & Buster’s was still in the early stages of a turnaround, with macro pressure remaining elevated and visibility limited, an eventual return to consistently positive same-store...
Via
Stocktwits
Caleres Draws ‘Less Risk’ Rating From Telsey, Retail Chatter Surges 700%
↗
September 05, 2025
Via
Stocktwits
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.